Kardigan Upsized IPO Priced at High End of Expectations

Dow Jones
Yesterday
 

By Colin Kellaher

 

Shares of Kardigan are set to make their trading debut Thursday after the clinical-stage precision therapeutics company's upsized initial public offering was priced at the top of expectations, raising $400 million.

Kardigan late Wednesday said it is selling 25 million shares at $16 apiece in the IPO, compared with prior plans to offer more than 23.3 million shares at between $14 and $16 each.

The pricing gives the Princeton, N.J., company an initial market capitalization of nearly $1.5 billion, assuming the underwriters exercise an option to buy an additional 3.75 million shares.

Kardigan shares are due to begin trading later Thursday on the Nasdaq Global Market under the symbol KARD.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

June 18, 2026 05:54 ET (09:54 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10